Nuformix plc
NFX.L · LSE
9/30/2024 | 9/30/2023 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | £0 | £0 | – | £0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | £0 | £0 | – | £0 |
| Gross Profit | £0 | -£0 | – | £0 |
| % Margin | – | – | – | 22.7% |
| R&D Expenses | £0 | £0 | – | £1 |
| G&A Expenses | £1 | £1 | – | £0 |
| SG&A Expenses | £1 | £1 | – | £1 |
| Sales & Mktg Exp. | £0 | £0 | – | £1 |
| Other Operating Expenses | £3 | -£0 | – | £0 |
| Operating Expenses | £4 | £1 | – | £1 |
| Operating Income | -£4 | -£1 | – | -£1 |
| % Margin | – | – | – | -2,540.5% |
| Other Income/Exp. Net | £0 | £0 | – | £0 |
| Pre-Tax Income | -£4 | -£1 | – | -£1 |
| Tax Expense | -£0 | -£0 | – | -£0 |
| Net Income | -£4 | -£1 | – | -£1 |
| % Margin | – | – | – | -2,218% |
| EPS | -0.005 | -0.001 | – | -0.002 |
| % Growth | -475% | – | – | – |
| EPS Diluted | -0.005 | -0.001 | – | -0.002 |
| Weighted Avg Shares Out | 787 | 719 | – | 598 |
| Weighted Avg Shares Out Dil | 787 | 719 | – | 598 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | – | £0 |
| Interest Expense | £0 | £0 | – | £0 |
| Depreciation & Amortization | £0 | £0 | – | £0 |
| EBITDA | -£0 | -£1 | – | -£1 |
| % Margin | – | – | – | -2,466.6% |